Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains

Oncogene

Volumn 22, Issue 38, 2003, Pages 6054-6060

  Rimoldi, Valeria ^a   Reversi, Alessandra ^a   Taverna, Elena ^a   Rosa, Patrizia ^a   Francolini, Maura ^b   Cassoni, Paola ^c   Parenti, Marco ^d   Chini, Bice ^a  

^a CNR   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Caveolin; EGFR; MAPK; Oxytocin receptor; p21

Indexed keywords

CAVEOLIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; OXYTOCIN RECEPTOR; PROTEIN P21;

ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CAVEOLAE; CAVEOLIN 1; CAVEOLIN 2; CAVEOLINS; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME ACTIVATION; ENZYME INHIBITORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MEMBRANE MICRODOMAINS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, OXYTOCIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TYROSINE;

EID: 0141596156     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206612     Document Type: Article

References (44)

1. Adachi T, Kar S, Wang M and Carr BI. (2002). J. Cell Physiol., 192, 151-159.
2. Anderson RG. (1993). Proc. Natl. Acad. Sci. USA, 90, 10909-10913.
3. Breton C, Haenggeli C, Barberis C, Heitz F, Bader CR, Bernheim L and Tribollet E. (2002). J. Clin. Endocrinol. Metab., 87, 1415-1418.
4. Bromberg JF, Fan Z, Brown C, Mendelsohn J and DarnellJr JE. (1998). Cell Growth Differ., 9, 505-512.
5. Bussolati G and Cassoni P. (2001). Endocrinology, 142, 1130-1136.
6. Carpenter G. (1999). J. Cell Biol., 146, 697-702.
7. Carpenter G. (2000). BioEssays, 22, 697-707.
8. Copland JA, Ives KL, Simmons DJ and Soloff MS. (1999). Endocrinology, 140, 4371-4374.
9. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD and Bunnett NW. (2000). J. Cell Biol., 148, 1267-1281.
10. Dessy C, Kelly RA, Balligand JL and Feron O. (2000). EMBO J., 19, 4272-4280.
11. Fan Z, Lu Y, Wu X, DeBlasio A, Koff A and Mendelsohn J. (1995). J. Cell Biol., 131, 235-242.
12. Filmus J, Pollak MN, Cailleau R and Buick RN. (1985). Biochem. Biophys. Res. Commun., 128, 898-905.
13. Florio T, Yao H, Carey KD, Dillon TJ and Stork PJ. (1999). Mol. Endocrinol., 13, 24-37.
14. Galbiati F, Razani B and Lisanti MP. (2001). Cell, 106, 403-411.
15. Giles KM, Daly JM, Beveridge DJ, Thomson AM, Voon DC, Furneaux HM, Jazayeri JA and Leedman PJ. (2003). J. Biol. Chem., 278, 2937-2946.
16. Gschwind A, Zwick E, Prenzel N, Leserer M and Ullrich A. (2001). Oncogene, 20, 1594-1600.
17. Gutkind JS. (1998). Oncogene, 17, 1331-1342.
18. Guzzi F, Zanchetta D, Cassoni P, Guzzi V, Francolini M, Parenti M and Chini B. (2002). Oncogene, 21, 1658-1667.
19. Jakus J and Yeudall WA. (1996). Oncogene, 12, 2369-2376.
20. Janes PW, Ley SC, Magee AI and Kabouridis PS. (2000). Semin. Immunol., 12, 23-34.
21. Johannessen LE, Knardal SL and Madshus IH. (1999). Biochem. J., 337 (Part 3), 599-606.
22. Laemmli UK. (1970). Nature, 227, 680-685.
23. Liebmann C. (2001). Cell Signal., 13, 777-785.
24. Ma YC, Huang J, Ali S, Lowry W and Huang XY. (2000). Cell, 102, 635-646.
25. Marshall CJ. (1995). Cell, 80, 179-185.
26. Mineo C, Gill GN and Anderson RG. (1999). J. Biol. Chem., 274, 30636-30643.
27. Moore JJ, Dubyak GR, Moore RM and Kooy DV. (1988). Endocrinology, 123, 1771-1777.
28. Oh P and Schnitzer JE. (2001). Mol. Biol. Cell, 12, 685-698.
29. Okamoto T, Schlegel A, Scherer PE and Lisanti MP. (1998). J. Biol. Chem., 273, 5419-5422.
30. Paquin J, Danalache BA, Jankowski M, McCann SM and Gutkowska J. (2002). Proc. Natl. Acad. Sci. USA, 99, 9550-9555.
31. Phaneuf S, Europe-Finner GN, Varney M, MacKenzie IZ, Watson SP and Lopez Bernal A. (1993). J. Endocrinol, 136, 497-509.
32. Pierce KL, Luttrell LM and Lefkowitz RJ. (2001). Oncogene, 20, 1532-1539.
33. Prenzel N, Fischer OM, Streit S, Hart S and Ullrich A. (2001). Endocr. Relat. Cancer, 8, 11-31.
34. Roovers K and Assoian RK. (2000). BioEssays, 22, 818-826.
35. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR and Anderson RG. (1992). Cell, 68, 673-682.
36. Rybin VO, Xu X, Lisanti MP and Steinberg SF. (2000). J. Biol. Chem., 275, 41447-41457.
37. Sanborn BM. (2001). Exp. Physiol., 86, 223-237.
38. Simons K and Toomre D. (2000). Nat. Rev. Mol. Cell. Biol., 1, 31-39.
39. Sorkin A and Von Zastrow M. (2002). Nat. Rev. Mol. Cell. Biol., 3, 600-614.
40. Strakova Z and Soloff MS. (1997). Am. J. Physio., 272, E870-E876.
41. Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA and Erzurum SC. (1999). Endocrinology, 140, 1301-1309.
42. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK and Alexander RW. (2001). J. Biol. Chem., 3, 3.
43. Volmat V and Pouyssegur J. (2001). Biol. Cell, 93, 71-79.
44. Xie W, Su K, Wang D, Paterson AJ and Kudlow JE. (1997). Anticancer Res., 17, 2627-2633.